The Dexcom ONE+ system features a one-touch sensor applicator, differing from Dexcom ONE which has a separate transmitter. It is 60% smaller than the ONE device. Dexcom also released its State of ...

The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

It's the longest-lasting wearable on the market. The G7 15-day sensor builds on the technology and performance of the Dexcom G7 CGM, which has proven to lower A1C and reduce hyper- and hypoglycemia.

The FDA raised concerns with a design change to a component used in the resistance layer of Dexcom’s sensors. The sensors with the new component were less accurate than those with the original ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A strong fourth-quarter 2024 performance and a series of favorable coverage decisions are ...

Dexcom has won a clearance from the FDA for its longest-lasting continuous glucose monitor, a 15-day version of its flagship G7 sensor. The new system, which boosts wear time up from the previous ...

DexCom DXCM received a warning letter from the FDA on March 4, 2025, following inspections of its San Diego and Mesa facilities in 2024. The FDA cited deficiencies in the company’s manufacturing ...